ATLASKyntra Bio (KYNB) earnings date: Nov 9, 2026
Kyntra Bio (KYNB) reports earnings for the quarter ended Sep 30, 2026 on Mon, Nov 9, 2026, after the close. Analysts expect EPS of -$3.66.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on KYNB
| Last price | $4.57 (-1.7%) |
|---|---|
| Normal 1-day range (±1σ) | ±4.4% |
| Earnings beat history | Beat the EPS estimate in 3 of the last 5 reports |
These figures come from the same calibrated model and valuation as the Kyntra Bio stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Kyntra Bio reports on Nov 9, 2026. One email the day before, with ATLAS’s read on Kyntra Bio. You can switch it off at any time.
Alert me before KYNB reportsFree to start. Creating an account takes under a minute.
Notify me when Kyntra Bio reports
Track KYNB free Add Kyntra Bio to a free ATLAS watchlist and see its next report date in one place.
KYNB earnings at a glance
| Next report (confirmed) | Mon, Nov 9, 2026 |
|---|---|
| Time | After the close |
| Period | Quarter ended Sep 30, 2026 |
| EPS estimate | -$3.66 |
| Last report | Aug 13, 2026 · Miss |
| Beat rate (last 5 reports) | 3 of 5 (60%) |
| Average EPS surprise | +259.0% |
| Average move around a report | ±4.8% (last 5) |
| Sector | Healthcare · Biotechnology |
Kyntra Bio earnings history: last 5 reports
Kyntra Bio last reported on Aug 13, 2026: EPS of -$4.69 against an estimate of -$3.18 (-47.5% surprise), a miss.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Aug 13, 2026 | -$3.18 | -$4.69 | -47.5% | Miss | -0.7% |
| May 11, 2026 | -$3.35 | -$3.76 | -12.2% | Miss | +4.0% |
| Mar 16, 2026 | -$3.88 | -$3.51 | +9.5% | Beat | +5.7% |
| Jan 15, 2026 | $2.98 | $3.14 | +5.4% | Beat | -3.8% |
| Nov 10, 2025 | -$4.00 | $49.61 | +1,340.0% | Beat | -9.9% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for KYNB
See the fair value, the probability range and the earnings history of Kyntra Bio on its ATLAS page.
Kyntra Bio (KYNB) stock analysisPlans from €3.99 a month.
Kyntra Bio earnings: frequently asked questions
When does Kyntra Bio (KYNB) report earnings?
Kyntra Bio is scheduled to report on Monday, November 9, 2026, after the close. ATLAS only shows a confirmed date when the company or the exchange data provides one; check the investor relations page for the call details.
What is the EPS estimate for KYNB?
The consensus EPS estimate for the quarter ended Sep 30, 2026 is -$3.66 per share (USD). Estimates can change before the report.
How often does KYNB beat earnings estimates?
Of its last 5 reports with a recorded result, Kyntra Bio beat the EPS estimate 3 times; the average surprise was +259.0%. Past results do not predict the next one.
How much does KYNB move around earnings?
Over its last 5 reports the stock moved an average of 4.8% (absolute, from the close before the report day to the close after it), and finished higher 2 of 5 times.
Did Kyntra Bio beat earnings estimates last quarter?
Kyntra Bio last reported on Aug 13, 2026: EPS of -$4.69 against an estimate of -$3.18 (-47.5% surprise), a miss.
How much does KYNB usually move in a day?
On a normal trading day the ATLAS model puts KYNB’s one-day range at about ±4.4%, with a 49% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Also reporting on Mon, Nov 9, 2026
Educational information, not investment advice. Disclaimer